サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1683255

リアルワールドエビデンスソリューションの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測

Global Real World Evidence Solutions Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 152 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
リアルワールドエビデンスソリューションの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測
出版日: 2025年03月01日
発行: Value Market Research
ページ情報: 英文 152 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

リアルワールドエビデンスソリューションの世界市場規模は、2024年の33億7,000万米ドルから2033年には72億9,000万米ドルに成長し、2026～2033年の予測期間中に8.93％の堅調な年間平均成長率（CAGR）を示すと予測されています。

世界のリアルワールドエビデンス（RWE）ソリューション市場は、医療の意思決定におけるデータ主導洞察に対する需要の高まりに後押しされ、大幅な成長を遂げる展望です。RWEは、患者の健康状態や医療の提供に関する情報を含む実世界データの分析から得られる臨床エビデンスを指します。製薬会社、支払者、規制機関を含む医療エコシステムの利害関係者が治療の有効性と安全性の理解を深めようとする中、RWEソリューションの採用は大幅に増加すると予想されます。この動向は、バリュー・ベースケアの重視の高まりと、償還決定に情報を提供するためのエビデンスの必要性によってさらに支えられています。

さらに、データ分析と技術の進歩は、RWEソリューションの展望を一変させると予想されます。ビッグデータ、機械学習、人工知能の統合は、膨大な量の実世界データを分析する能力を強化し、臨床実践や施策に情報を提供できる実用的な洞察を提供しています。さらに、電子カルテや患者登録の利用可能性が高まることで、質の高いデータの収集が容易になり、RWEソリューションの需要がさらに高まっています。医療組織が臨床戦略や商業戦略をサポートするリアルワールドエビデンスの価値をますます認識するようになるにつれ、市場はこうしたニーズに対応する革新的なソリューションの急増を目の当たりにすることになると考えられます。

さらに、患者エンゲージメントへの関心の高まりと患者報告アウトカムの重要性は、RWEソリューション市場の将来を形成すると予想されます。患者が医療の意思決定に関与するようになるにつれ、患者の経験と転帰を把握するソリューションの必要性がますます高まっています。患者の視点を取り入れたRWEソリューションは、治療効果をより包括的に理解することができ、最終的には患者ケアの改善につながります。RWEソリューション市場がエビデンスによる医療の最前線であり続けるためには、データプロバイダー、医療機関、規制機関の協力が不可欠です。

当社のレポートは、様々な産業や市場に関する包括的かつ実用的な洞察を顧客に提供するために綿密に作成されています。各レポートは、市場情勢を完全に理解するために、いくつかの重要な要素を含んでいます。

市場概要：市場概要：定義、分類、産業の現状など、市場に関する詳細なイントロダクション。

市場促進要因：市場成長に影響を与える主要促進要因・抑制要因・市場促進要因・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに内訳。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場参入企業の包括的評価。主要企業が採用する競合力学と主要戦略に関する考察を記載しています。

市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域による市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネス機会を理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象セグメントを特定します。将来の市場開拓と成長展望に関する洞察を記載しています。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 リアルワールドエビデンスソリューション産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 産業動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原料分析
    • 原料リスト
    • 原料メーカー一覧
    • 主要原料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • 直接マーケティング
    • 間接マーケティング
    • マーケティングチャネル発展動向

第5章 リアルワールドエビデンスソリューションの世界市場分析：コンポーネント別

  • コンポーネント別概要
  • コンポーネント別過去・予測データ分析
  • サービス
  • データセット

第6章 リアルワールドエビデンスソリューションの世界市場分析：用途別

  • 用途別概要
  • 用途別過去・予測データ分析
  • 医薬品開発・承認
  • 医療機器の開発と承認
  • 償還/保険適用と規制上の意思決定
  • 市販後の安全性と有害事象モニタリング

第7章 世界のリアルワールドエビデンスソリューション市場分析：最終用途別

  • 最終用途別概要
  • 最終用途別過去・予測データ分析
  • 医療企業（製薬、バイオ医薬品、医療機器）
  • 医療事業者
  • 医療プロバイダー
  • その他

第8章 リアルワールドエビデンスソリューションの世界市場分析：治療セグメント別

  • 治療領域別概要
  • 治療領域別過去・予測データ分析
  • 腫瘍学
  • 循環器
  • 神経学
  • 糖尿病
  • 精神科
  • 呼吸器科
  • その他

第9章 リアルワールドエビデンスソリューションの世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第10章 リアルワールドエビデンスソリューション企業の競合情勢

  • リアルワールドエビデンスソリューション市場競合
  • 提携・協力・契約
  • 合併・買収
  • 新製品発売
  • その他の開発

第11章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • IQVIA Inc.
  • IBM
  • PPD Inc.（Thermo Fisher Scientific Inc.が買収）
  • Parexel International（MA）Corporation
  • PerkinElmer Inc.
  • ICON Plc
  • Oracle
  • Syneos Health
  • Cegedim Health Data
  • Medpace
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Component (USD MN)
  • Services Market Sales By Geography (USD MN)
  • Data Sets Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Drug Development & Approvals Market Sales By Geography (USD MN)
  • Medical Device Development & Approvals Market Sales By Geography (USD MN)
  • Reimbursement/Coverage and Regulatory Decision Making Market Sales By Geography (USD MN)
  • Post Market Safety & Adverse Events Monitoring Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Healthcare Companies (Pharmaceutical, Biopharmaceutical, Medical Device) Market Sales By Geography (USD MN)
  • Healthcare Payers Market Sales By Geography (USD MN)
  • Healthcare Providers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Therapeutic Area (USD MN)
  • Oncology Market Sales By Geography (USD MN)
  • Cardiology Market Sales By Geography (USD MN)
  • Neurology Market Sales By Geography (USD MN)
  • Diabetes Market Sales By Geography (USD MN)
  • Psychiatry Market Sales By Geography (USD MN)
  • Respiratory Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Real World Evidence Solutions Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Real World Evidence Solutions Report
  • Market Research Process
  • Market Research Methodology
  • Global Real World Evidence Solutions Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Component
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Therapeutic Area
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Component (USD MN)
  • Services Market Sales By Geography (USD MN)
  • Data Sets Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Drug Development & Approvals Market Sales By Geography (USD MN)
  • Medical Device Development & Approvals Market Sales By Geography (USD MN)
  • Reimbursement/Coverage and Regulatory Decision Making Market Sales By Geography (USD MN)
  • Post Market Safety & Adverse Events Monitoring Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Healthcare Companies (Pharmaceutical, Biopharmaceutical, Medical Device) Market Sales By Geography (USD MN)
  • Healthcare Payers Market Sales By Geography (USD MN)
  • Healthcare Providers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Therapeutic Area (USD MN)
  • Oncology Market Sales By Geography (USD MN)
  • Cardiology Market Sales By Geography (USD MN)
  • Neurology Market Sales By Geography (USD MN)
  • Diabetes Market Sales By Geography (USD MN)
  • Psychiatry Market Sales By Geography (USD MN)
  • Respiratory Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11212359

Global Real World Evidence Solutions Market size is anticipated to grow from USD 3.37 Billion in 2024 to USD 7.29 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 8.93% during the forecast period of 2026 to 2033.

The global real-world evidence (RWE) solutions market is set to witness substantial growth, driven by the increasing demand for data-driven insights in healthcare decision-making. RWE refers to the clinical evidence derived from the analysis of real-world data, which includes information on patient health status and the delivery of healthcare. As stakeholders in the healthcare ecosystem, including pharmaceutical companies, payers, and regulatory agencies, seek to enhance the understanding of treatment effectiveness and safety, the adoption of RWE solutions is expected to rise significantly. This trend is further supported by the growing emphasis on value-based care and the need for evidence to inform reimbursement decisions.

Moreover, advancements in data analytics and technology are anticipated to transform the RWE solutions landscape. The integration of big data, machine learning, and artificial intelligence is enhancing the ability to analyze vast amounts of real-world data, providing actionable insights that can inform clinical practice and policy. Additionally, the increasing availability of electronic health records and patient registries is facilitating the collection of high-quality data, further driving the demand for RWE solutions. As healthcare organizations increasingly recognize the value of real-world evidence in supporting clinical and commercial strategies, the market is likely to witness a surge in innovative solutions that cater to these needs.

In addition, the growing focus on patient engagement and the importance of patient-reported outcomes are expected to shape the future of the RWE solutions market. As patients become more involved in their healthcare decisions, the need for solutions that capture their experiences and outcomes is becoming increasingly important. RWE solutions that incorporate patient perspectives can provide a more comprehensive understanding of treatment impact, ultimately leading to improved patient care. Collaborative efforts between data providers, healthcare organizations, and regulatory bodies will be essential in driving these advancements, ensuring that the RWE solutions market remains at the forefront of evidence-based healthcare.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Component

  • Services
  • Data Sets

By Application

  • Drug Development & Approvals
  • Medical Device Development & Approvals
  • Reimbursement/Coverage and Regulatory Decision Making
  • Post Market Safety & Adverse Events Monitoring

By End-use

  • Healthcare Companies (Pharmaceutical, Biopharmaceutical, Medical Device)
  • Healthcare Payers
  • Healthcare Providers
  • Others

By Therapeutic Area

  • Oncology
  • Cardiology
  • Neurology
  • Diabetes
  • Psychiatry
  • Respiratory
  • Others
  • COMPANIES PROFILED
  • IQVIA Inc.
  • IBM
  • PPD Inc. (acquired by Thermo Fisher Scientific Inc.)
  • Parexel International (MA) Corporation
  • PerkinElmer Inc.
  • ICON plc
  • Oracle
  • Syneos Health
  • Cegedim Health Data
  • Medpace.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. REAL WORLD EVIDENCE SOLUTIONS INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Component
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End-use
    • 3.7.4 Market Attractiveness Analysis By Therapeutic Area
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL REAL WORLD EVIDENCE SOLUTIONS MARKET ANALYSIS BY COMPONENT

  • 5.1. Overview By Component
  • 5.2. Historical and Forecast Data Analysis By Component
  • 5.3. Services Historic and Forecast Sales By Regions
  • 5.4. Data Sets Historic and Forecast Sales By Regions

6. GLOBAL REAL WORLD EVIDENCE SOLUTIONS MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data Analysis By Application
  • 6.3. Drug Development & Approvals Historic and Forecast Sales By Regions
  • 6.4. Medical Device Development & Approvals Historic and Forecast Sales By Regions
  • 6.5. Reimbursement/Coverage and Regulatory Decision Making Historic and Forecast Sales By Regions
  • 6.6. Post Market Safety & Adverse Events Monitoring Historic and Forecast Sales By Regions

7. GLOBAL REAL WORLD EVIDENCE SOLUTIONS MARKET ANALYSIS BY END-USE

  • 7.1. Overview By End-use
  • 7.2. Historical and Forecast Data Analysis By End-use
  • 7.3. Healthcare Companies (Pharmaceutical, Biopharmaceutical, Medical Device) Historic and Forecast Sales By Regions
  • 7.4. Healthcare Payers Historic and Forecast Sales By Regions
  • 7.5. Healthcare Providers Historic and Forecast Sales By Regions
  • 7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL REAL WORLD EVIDENCE SOLUTIONS MARKET ANALYSIS BY THERAPEUTIC AREA

  • 8.1. Overview By Therapeutic Area
  • 8.2. Historical and Forecast Data Analysis By Therapeutic Area
  • 8.3. Oncology Historic and Forecast Sales By Regions
  • 8.4. Cardiology Historic and Forecast Sales By Regions
  • 8.5. Neurology Historic and Forecast Sales By Regions
  • 8.6. Diabetes Historic and Forecast Sales By Regions
  • 8.7. Psychiatry Historic and Forecast Sales By Regions
  • 8.8. Respiratory Historic and Forecast Sales By Regions
  • 8.9. Others Historic and Forecast Sales By Regions

9. GLOBAL REAL WORLD EVIDENCE SOLUTIONS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE REAL WORLD EVIDENCE SOLUTIONS COMPANIES

  • 10.1. Real World Evidence Solutions Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF REAL WORLD EVIDENCE SOLUTIONS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. IQVIA Inc.
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. IBM
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. PPD Inc. (Acquired By Thermo Fisher Scientific Inc.)
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Parexel International (MA) Corporation
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. PerkinElmer Inc.
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. ICON Plc
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Oracle
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Syneos Health
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Cegedim Health Data
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Medpace
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies